Bangladesh vs Senegal: Hepatitis B surface antigen (HBsAg) prevalence
Bangladesh
0.4%
in 2024
Senegal
0.4%
in 2024
Bangladesh rank
62nd
Senegal rank
62nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Bangladesh
- Senegal
How they compare
Bangladesh currently reports 0.4% against 0.4% in Senegal, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Senegal ahead.
Bangladesh ranks 62nd and Senegal ranks 62nd of 194 countries.
Across the 2 decades both report, Bangladesh averaged higher in 1 and Senegal in 1.
Head to head by decade
| Decade | Bangladesh | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.7% | 0.8% | 0.2% | Senegal |
| 2020s | 0.5% | 0.5% | 0.0% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Bangladesh or Senegal?
- Bangladesh, at 0.4% against 0.4% in Senegal as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Bangladesh and Senegal?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Senegal?
- 10 years are reported by both, from 2015 to 2024.
- How do Bangladesh and Senegal rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Bangladesh ranks 62nd and Senegal ranks 62nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.